We use cookies to provide you with a better website experience. By continuing to use this site, you are agreeing to our use of cookies. Please view our Cookie Policy to learn more.
Lisa Dwyer comments on the FDA recently releasing final guidance to help small entities that make laboratory-developed tests comply with the final LDT rule